MiR-212 inhibits cell proliferation, migration, and invasion in renal cell carcinoma (RCC) and exerts tumor suppressor effects by downregulating T-box transcription factor TBX15 (TBX15) [51,52]. Here, TBXT is linked to renal cell carcinoma.